PREVENTIVE MEDICINE

AAA
The USPSTF recommends one-time screening for abdominal aortic aneurysm (AAA)
with ultrasonography in men ages 65 to 75 years who have ever smoked.
ALCOHOL
The USPSTF recommends that clinicians screen adults aged 18 years or older for
alcohol misuse and provide persons engaged in risky or hazardous drinking with
brief behavioral counseling interventions to reduce alcohol misuse
ASPIRIN
The USPSTF recommends the use of aspirin for men age 45 to 79 years
The USPSTF recommends the use of aspirin for women age 55 to 79 years
The USPSTF recommends against the routine use of aspirin and nonsteroidal anitinflammatory drugs (NSAIDS) to prevent colorectal cancer in individuals at average
risk for colorectal cancer.
ASYMPTOMATIC BACTERIURIA
The USPSTF recommends screening for asymptomatic bacteriuria with urine culture
for pregnant women at 12 to 16 weeks' gestation or at their first prenatal visit, if
later.
BLOOD PRESSURE
The U.S. Preventive Services Task Force (USPSTF) recommends screening for high
blood pressure in adults 18 and over.
BREAST CANCER
The USPSTF recommends biennial screening mammography for women 50-74 years.
The USPSTF recommends against teaching breast self-examination (BSE).
SYPHILIS
The USPSTF recommends that clinicians screen all pregnant women for syphilis
infection.
CERVICAL CANCER
The USPSTF recommends screening for cervical cancer in women age 21 to 65
years with cytology (Pap smear) every 3 years or, for women age 30 to 65 years

who want to lengthen the screening interval, screening with a combination of

cytology and human papillomavirus (HPV) testing every 5 years

GONORRHEA
The USPSTF recommends screening for gonorrhea in sexually active women age 24
years and younger and in older women who are at increased risk for infection.
CHLAMYDIA
The USPSTF recommends screening for chlamydia in sexually active women age 24
years and younger and in older women who are at increased risk for infection.
CONGENITAL HYPOTHYRODISM
The United States Preventive Services Task Force (USPSTF) recommends screening
for congenital hypothyroidism (CH) in newborns.
FLOURIDE DEFICENCY
The USPSTF recommends that primary care clinicians prescribe oral fluoride
supplementation starting at age 6 months for children whose water supply is
deficient in fluoride
DIABETES
The USPSTF recommends screening for type 2 diabetes in asymptomatic adults with
sustained blood pressure (either treated or untreated) greater than 135/80 mm Hg.
HBV
The USPSTF recommends screening for hepatitis B virus (HBV) infection in pregnant
women at their first prenatal visit.
HCV
The USPSTF recommends screening for hepatitis C virus (HCV) infection in persons
at high risk for infection. The USPSTF also recommends offering 1-time screening for
HCV infection to adults born between 1945 and 1965.
HIV
The USPSTF recommends that clinicians screen for HIV infection in adolescents and
adults aged 15 to 65 years.
IRON DEFICENCY ANEMIA

The USPSTF recommends routine screening for iron deficiency anemia in

asymptomatic pregnant women.

LUNG CANCER
The USPSTF recommends annual screening for lung cancer with low-dose computed
tomography (LDCT) in adults aged 55 to 80 years who have a 30 pack-year
smoking history and currently smoke or have quit within the past 15 years.
Screening should be discontinued once a person has not smoked for 15 years or
develops a health problem that substantially limits life expectancy or the ability or
willingness to have curative lung surgery.
OBESITY
The USPSTF recommends screening all adults for obesity. Clinicians should offer or
refer patients with a body mass index (BMI) of 30 kg/m2 or higher to intensive,
multicomponent behavioral interventions.
NO SCREENING FOR:
No screening for testicular cancer, pancreatic cancer, bladder cancer,
ovarian cancer, carotid artery stenosis ,CKD,COPD,cognitive
impairment,DDH

UPTODATE
For women who have not undergone risk-reducing surgery, breast and/or
ovarian cancer surveillance entails (see 'Cancer surveillance' above):
Consideration of monthly breast self-examination beginning at age 18.
Clinical breast examination two to four times annually beginning at age
25.
Annual mammography and breast magnetic resonance imaging (MRI)
screening (commonly alternated every six months) beginning at age 25 or
individualized based on the earliest age of onset in the family. However,
women between the ages of 25 to 30 may consider MRI only, with annual
mammography added after age 30.
Twice yearly ovarian cancer screening with transvaginal ultrasound and
serum CA-125 levels (preferably day 1 to 10 of menstrual cycle for
premenopausal women) beginning at age 30, or 5 to 10 years earlier than
the earliest age of first diagnosis of ovarian cancer in the family

Dr.Ala Hawa